Log In
Print
BCIQ
Print
Print this Print this
 

AMR-001, NBS10 (formerly NBS-10)

  Manage Alerts
Collapse Summary General Information
Company NeoStem Inc.
DescriptionAutologous bone marrow-derived stem cells
Molecular Target CD34 ; CXC chemokine receptor 4 (CXCR4) (NPY3R)
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase II
Standard IndicationMyocardial infarction (MI)
Indication DetailsPreserve heart muscle function after ST elevation myocardial infarction (STEMI); Treat acute myocardial infarction (MI)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$15.7M

0

$5.9M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today